News
Team recommends melanoma screening in CLL
Patients with chronic lymphocytic leukemia (CLL) should be routinely monitored for melanoma, according to researchers. A study of 470 CLL patients...
News
Frequent BCCs linked to blood cancers
New research suggests people who develop frequent cases of basal cell carcinoma (BCC) have an increased risk of leukemias, lymphomas, and other...
News
Comprehensive sequencing informs treatment for MM
A comprehensive RNA and DNA sequencing platform can guide treatment decisions for late-stage and drug-resistant multiple myeloma (MM), according...
News
Tool identifies potential treatment for resistant MM
Researchers say they have developed a computational platform that can be used to identify optimal treatments for multiple myeloma (MM). Using...
News
FDA approves mogamulizumab for MF, SS
The US Food and Drug Administration (FDA) has approved mogamulizumab-kpkc (Poteligeo®) for the treatment of adults with relapsed or refractory...
News
Health Canada approves emicizumab
Health Canada has approved emicizumab (Hemlibra®) for use as routine prophylaxis to prevent or reduce bleeding episodes in hemophilia A patients...
News
Drug could be repurposed for T-ALL
Venetoclax might improve the treatment of certain patients with T-cell acute lymphoblastic leukemia (T-ALL), according to preclinical research...
News
FDA grants fast track designation to dilanubicel
The US Food and Drug Administration (FDA) has granted fast track designation to dilanubicel (NLA101) for use in patients with high-risk...
News
A new way to expand HSCs for UCB transplant
Researchers say they have discovered a new approach to expand hematopoietic stem cells (HSCs) from umbilical cord blood (UCB). The team...
News
Treatment guidelines for CAR T-cell therapy
Researchers have developed treatment guidelines for pediatric patients receiving chimeric antigen receptor (CAR) T-cell therapy. The guidelines...
News
FDA advises against azithromycin use in allo-HSCT recipients
The US Food and Drug Administration (FDA) is warning against long-term use of azithromycin (Zithromax, Zmax) in patients who undergo allogeneic...
News
Company stops development of drug for MM
MorphoSys AG has decided to stop developing MOR202 as a treatment for multiple myeloma (MM). However, MorphoSys said it will complete the ongoing...
News
Company narrows focus of development for tazemetostat
Epizyme, Inc., has announced its decision to stop developing tazemetostat for use as monotherapy or in combination with prednisolone for patients...
News
Orphan designation recommended for PCM-075
The European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has recommended that PCM-075 receive orphan drug designation as a...
News
Work explains link between hypoxia and thrombosis
Researchers say they have discovered how hypoxia increases the risk of thrombosis. The team noted that the cellular response to hypoxia is...